SILO PHARMA, INC. Interest Expense
SILO PHARMA, INC. (SILO) reported Interest Expense of $1.87 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-13
- SILO PHARMA, INC. interest expense for the quarter ending 2024-03-31 was $1.87K, a 12.99% increase year-over-year.
- SILO PHARMA, INC. interest expense for the quarter ending 2023-12-31 was $273.00.
- SILO PHARMA, INC. interest expense for the quarter ending 2023-09-30 was $1.08K.
- SILO PHARMA, INC. interest expense for the quarter ending 2023-06-30 was $1.86K.
- SILO PHARMA, INC. interest expense for fiscal 2023 was $4.87K, a 121.42% increase from fiscal 2022.
- SILO PHARMA, INC. interest expense for fiscal 2022 was $2.20K, a 27.57% decline from fiscal 2021.
- SILO PHARMA, INC. interest expense for fiscal 2021 was $3.04K, a 3695.00% increase from fiscal 2020.
- SILO PHARMA, INC. interest expense for fiscal 2020 was $80.00.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2024-03-31 | $1.87K 10-Q · filed 2024-05-13 | $2.14K derived: sum of 2 quarters · filed 2024-05-13 | $3.22K derived: sum of 3 quarters · filed 2024-05-13 | $5.08K derived: sum of 4 quarters · filed 2024-05-13 | |
| 2023-12-31 | $273.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $1.35K derived: sum of 2 quarters · filed 2024-03-25 | $3.21K derived: sum of 3 quarters · filed 2024-03-25 | $4.87K 10-K · filed 2024-03-25 | |
| 2023-09-30 | $1.08K 10-Q · filed 2023-11-13 | $2.94K derived: sum of 2 quarters · filed 2023-11-13 | $4.60K 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | $1.86K 10-Q · filed 2023-08-11 | $3.52K 10-Q · filed 2023-08-11 | |||
| 2023-03-31 | $1.66K 10-Q · filed 2024-05-13 | ||||
| 2022-12-31 | $2.20K 10-K · filed 2024-03-25 | ||||
| 2021-12-31 | $2.98K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $2.98K derived: sum of 2 quarters · filed 2023-03-24 | $2.99K derived: sum of 3 quarters · filed 2023-03-24 | $3.04K 10-K · filed 2023-03-24 | $54.00 10-K · filed 2022-03-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $7.00 derived: sum of 2 quarters · filed 2021-11-10 | $54.00 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $7.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $54.00 10-Q · filed 2021-08-13 | |||
| 2021-03-31 | $47.00 10-Q · filed 2021-05-17 | ||||
| 2020-12-31 | $80.00 10-K · filed 2022-03-28 | ||||
| 2020-03-31 | $82.50K 10-Q · filed 2020-05-12 | $81.64K derived: sum of 2 quarters · filed 2021-05-17 | $81.73K derived: sum of 3 quarters · filed 2021-05-17 | $82.05K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | -$864.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-17 | -$770.00 derived: sum of 2 quarters · filed 2021-05-17 | -$454.00 derived: sum of 3 quarters · filed 2021-05-17 | $0.00 10-K/A · filed 2021-05-17 | $62.74K 10-K · filed 2020-03-20 |
| 2019-09-30 | $94.00 10-Q · filed 2019-11-13 | $410.00 derived: sum of 2 quarters · filed 2019-11-13 | $864.00 10-Q · filed 2019-11-13 | ||
| 2019-06-30 | $316.00 10-Q · filed 2019-08-13 | $770.00 10-Q · filed 2019-08-13 | |||
| 2019-03-31 | $454.00 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |